Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure

Current Medical Research and Opinion

Volumn 31, Issue 12, 2015, Pages 2167-2173

  McHorney, Colleen A ^a   Crivera, Concetta ^b   Laliberté, François ^c   Nelson, Winnie W ^b   Germain, Guillaume ^c   Bookhart, Brahim ^b   Martin, Silas ^d   Schein, Jeffrey ^b   Lefebvre, Patrick ^c   Deitelzweig, Steven ^e  

^a ERT   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^c Groupe d analyse   (Canada)

^d JOHNSON AND JOHNSON   (United States)

^e OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Anticoagulant; Medication adherence; Patient adherence; Pharmacy Quality Alliance

Indexed keywords

APIXABAN; DABIGATRAN; RIVAROXABAN; ANTICOAGULANT AGENT; PYRAZOLE DERIVATIVE; PYRIDONE DERIVATIVE;

AGED; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PHARMACY QUALITY ALLIANCE MEASURE; RETROSPECTIVE STUDY; TOTAL QUALITY MANAGEMENT; UNITED STATES; COHORT ANALYSIS; ORAL DRUG ADMINISTRATION; VERY ELDERLY;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; COHORT STUDIES; DABIGATRAN; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; PYRAZOLES; PYRIDONES; RETROSPECTIVE STUDIES; RIVAROXABAN;

EID: 84955662069     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2015.1096242     Document Type: Article

References (25)

1. Cranston L, Dixon L. Emerging Trends in Adherence and Quality Measurement: What the Future Holds. Available at: Http://www. pharmacytimes.com/publications/Directions-in-Pharmacy/2014/August 2014/Emerging-Trends-in-Adherence-and-Quality-Measurement-What-the-Future-Holds [Last accessed January 2015]
2. Centers for Medicare & Medicaid Services. Medicare 2015 Part C & D Star Rating Technical Notes. Baltimore, MD: CMS, 2015
3. Academy of Managed Care Pharmacy, American Pharmacists Association. Medicare star ratings: Stakeholder proceedings on community pharmacy and managed care partnerships in quality. J Am Pharmacists Assoc 2014;54:228-40
4. Pharmacy Quality Alliance. Executive Update on Medication Quality Measures in Medicare Part D Plan Ratings. Available at: Http://pqaalliance.org/measures/cms.asp [Last accessed January 2015]
5. Rodriguez RA, Carrier M, Wells PS. Non-adherence to new oral anticoagulants: A reason for concern during long-term anticoagulation? J Thromb Haemostasis 2013;11:390-4
6. Hankey GJ, Eikelboom JW. Novel oral anticoagulants for atrial fibrillation. Curr Atheroscleros Rep 2013;15:1-11
7. Aditya S. Oral and parenteral anticoagulants: New kids on the block. J Postgrad Med 2012;58:275-85
8. Ansell J, Hirsh J, Hylek E, et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl 6):160-98S
9. Chatterjee S, Sardar P, Giri JS, et al. Treatment discontinuations with new oral agents for long-term anticoagulation: Insights from a meta-analysis of 18 randomized trials including 101,801 patients. Mayo Clin Proc 2014;89: 896-907
10. Crivera C, Nelson WW, Bookhart B, et al. Abstract 366: Pharmacy Quality Alliance measure: Adherence to non-warfarin oral anticoagulant medication. Circ Cardiovasc Qual Outcomes 2015;8(Suppl 2):A366
11. Pharmacy Quality Alliance (PQA). Technical specifications for PQA approved measures. Springfield, VA: Pharmacy Quality Alliance, 2014
12. Laliberte F, Bookhart BK, Nelson WW, et al. Impact of once-daily versus twicedaily dosing frequency on adherence to chronic medications among patients with venous thromboembolism. Patient 2013;6:213-24
13. Laliberté F, Cloutier M, Crivera C, et al. Effect of rivaroxaban versus warfarin on health care costs among nonvalvular atrial fibrillation patients: Observations from rivaroxaban users and matched warfarin users. Adv Ther 2015;32:216-27
14. Srivastava K, Arora A, Kataria A, et al. Impact of reducing dosing frequency on adherence to oral therapies: A literature review and meta-analysis. Patient Preference and Adherence 2013;7:419-34
15. US Food and Drug Administration. FDA approves Pradaxa to prevent stroke in people with atrial fibrillation. Available at: Http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm230241.htm [Last accessed January 2014]
16. US Food and Drug Administration. FDA approves Xarelto to prevent stroke in people with common type of abnormal heart rhythm. Available at: Http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm278646. htm [Last accessed January 2014]
17. US Food and Drug Administration. FDA approves Eliquis to reduce the risk of stroke, blood clots in patients with non-valvular atrial fibrillation. Available at: Http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm 333634.htm [Last accessed January 2014]
18. Choudhry NK, Fisher MA, Smith BF, et al. Five features of value-based insurance design plans were associated with higher rates of medication adherence. Health Affairs 2014;33:493-501
19. Maciejewski ML, Wansink D, Lindquist JH, et al. Value-based insurance design program in North Carolina increased medication adherence but was not cost neutral. Health Affairs 2014;33:300-8
20. Nau D. Pharmacy Quality Measurement and the Connection to Accountable Care. Available at: Http://www.asapnet.org/files/January2015/Presentations/ASAPJan15-Presentation03-Nau.pdf [Last accessed January 2015]
21. Centers for Medicare & Medicaid Services. Medicare Health & Drug Plan Quality and Performance Ratings 2012 Part C & Part D Technical Notes. Baltimore, MD: CMS, 2012
22. Centers for Medicare & Medicaid Services. Medicare Health & Drug Plan Quality and Performance Ratings 2013 Part C & Part D Technical Notes. Baltimore, MD: CMS, 2013
23. Centers for Medicare & Medicaid Services. Medicare 2014 Part C & D Star Rating Technical Notes. Baltimore, MD: CMS, 2014
24. Leslie RS, Tirado B, Patel BV, et al. Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures. J Manag Care Specialty Pharmacy 2014;20:1193-203
25. Reid RO, Deb P, Howell BL, et al. Association between Medicare Advantage plan star ratings and enrollment. JAMA 2013;309:267-74